ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
Source: Clinical Trials And Noteworthy Treatments For Brain Tumors - Category: Cancer & Oncology Source Type: clinical trials
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Clinical Trials | Immunotherapy | Neurology